Sign in

CIK 0001800315

  • Non-accelerated filer
  • Smaller reporting company

Damora Therapeutics, Inc.

Sign in to watch
Ticker
DMRA
Exchange
Nasdaq
Industry
Pharmaceutical Preparations
FY end
Dec 31
Incorporated
DE
Entity type
Operating
EIN
371957007
Phone
+1 781-281-9020
Business address
100 FIFTH AVENUE, SUITE 700, WALTHAM, MA, 02451
Former names
Galecto, Inc., Galecto Inc.
Open-market buys, last 90 days
$252,875
in 1 filing
Open-market sales, last 90 days
$0
in 0 filings

Net +$252,875. Shares bought or sold at a price by officers, directors and 10% owners (Form 4 codes P and S). Grants, option exercises and tax withholding aren't counted.

Pace of trading Bought Sold

Who's trading

90 days

  1. Jarrett Jennifer +$253K Director, President and CEO 1 filing
Date Insider Transaction Shares Price Value Owned after
2026-03-23 Fairmount Funds Management LLC Director Grant or award · Stock Option (right to buy) +37,313 37,313
2026-02-09 Fairmount Funds Management LLC Director Option exercise +5,809,000 5,809,000
2026-02-09 Fairmount Funds Management LLC Director Option exercise +2,904,000 2,904,000
2026-02-09 Fairmount Funds Management LLC Director Option exercise · Series C Preferred Stock −5,809 1,148
2026-02-09 Fairmount Funds Management LLC Director Option exercise · Series C Preferred Stock −2,904 574

Page 1 of 1 · 5 trades